Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Date Time Source Announcement
28 Jul 2021 5:32 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
2nd Quarter Results
26 Jul 2021 4:59 pm
RNS
Director/PDMR Shareholding
23 Jul 2021 2:32 pm
RNS
Board Committee Changes
22 Jul 2021 2:45 pm
RNS
CEO Designate of new Consumer Healthcare company
16 Jul 2021 12:00 pm
RNS
GSK announces daprodustat phase 3 headline results
  10:24 am
RNS
Director/PDMR Shareholding
15 Jul 2021 1:21 pm
RNS
Director/PDMR Shareholding
14 Jul 2021 3:34 pm
RNS
Director/PDMR Shareholding
  3:17 pm
RNS
Director/PDMR Shareholding
13 Jul 2021 9:44 am
RNS
Director/PDMR Shareholding
  9:33 am
RNS
Director/PDMR Shareholding
12 Jul 2021 10:23 am
RNS
Director/PDMR Shareholding
  10:18 am
RNS
Director/PDMR Shareholding
09 Jul 2021 9:30 am
RNS
Director/PDMR Shareholding
02 Jul 2021 12:36 pm
RNS
GSK and Alector collaboration in immuno-neurology
  10:41 am
RNS
Elliott Advisors (UK) letter to GSK
01 Jul 2021 2:29 pm
RNS
Total Voting Rights
25 Jun 2021 4:54 pm
RNS
Director/PDMR Shareholding
24 Jun 2021 11:07 am
RNS
Director/PDMR Shareholding
23 Jun 2021 11:00 am
RNS
GSK to deliver step-change in growth & performance
22 Jun 2021 7:00 am
RNS
ViiV/Halozyme sign exclusive licensing agreement
14 Jun 2021 11:58 am
RNS
GSK and iTeos announce collaboration for EOS-448
11 Jun 2021 4:54 pm
RNS
Director/PDMR Shareholding
09 Jun 2021 3:28 pm
RNS
Director/PDMR Shareholding
04 Jun 2021 4:02 pm
RNS
GSK recommend ADR holders reject mini-tender offer
01 Jun 2021 11:33 am
RNS
Total Voting Rights
27 May 2021 9:21 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
GSK/Vir Sotrovimab FDA Emergency Use Authorization
  7:00 am
RNS
Sanofi and GSK initiate new Phase 3 clinical study
24 May 2021 10:10 am
RNS
Director/PDMR Shareholding
21 May 2021 12:58 pm
RNS
GSK/VIR sotrovimab receives positive EMA opinion
18 May 2021 1:52 pm
RNS
Block listing Interim Review
  7:00 am
RNS
Medicago/GSK COVID-19 Vaccine Positive Ph2 Results
17 May 2021 7:00 am
RNS
Sanofi/GSK COVID-19 Vaccine Positive Ph2 Results
13 May 2021 4:46 pm
RNS
Director/PDMR Shareholding
11 May 2021 12:54 pm
RNS
Director/PDMR Shareholding
  11:30 am
RNS
EMTN Prospectus
06 May 2021 5:50 pm
RNS
Board and Committee Changes
05 May 2021 6:23 pm
RNS
Result of AGM
04 May 2021 4:29 pm
RNS
Total Voting Rights
28 Apr 2021 5:33 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
1st Quarter Results
26 Apr 2021 4:14 pm
RNS
Director/PDMR Shareholding
23 Apr 2021 3:00 pm
RNS
EU approves GSK's JEMPERLI (dostarlimab-gxly)
  7:00 am
RNS
FDA approves GSK's JEMPERLI (dostarlimab-gxly)
16 Apr 2021 4:00 pm
RNS
Director/PDMR Shareholding
15 Apr 2021 3:21 pm
RNS
Director/PDMR Shareholding
  10:17 am
RNS
Director/PDMR Shareholding
14 Apr 2021 2:14 pm
RNS
Director/PDMR Shareholding
  11:58 am
RNS
Director/PDMR Shareholding
12 Apr 2021 5:32 pm
RNS
Director/PDMR Shareholding
  9:48 am
RNS
Director/PDMR Shareholding
09 Apr 2021 5:34 pm
RNS
Director/PDMR Shareholding
  1:35 pm
RNS
Director/PDMR Shareholding
06 Apr 2021 2:30 pm
RNS
Directorate Change
01 Apr 2021 3:36 pm
RNS
Total Voting Rights
30 Mar 2021 4:21 pm
RNS
Publication of 2021 AGM Notice
  11:30 am
RNS
GSK respiratory product sales reporting changes
24 Mar 2021 12:30 pm
RNS
Moncef Slaoui Departs Galvani Bioelectronics
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t